HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹5.93 Cr | ₹7.41 Cr | ₹7.35 Cr | ₹6.51 Cr | ₹7.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹5.93 Cr |
| Mar2024 | ₹7.41 Cr |
| Mar2023 | ₹7.35 Cr |
| Mar2022 | ₹6.51 Cr |
| Mar2021 | ₹7.28 Cr |
How is Deferred Tax Assets / Liabilities of HESTER BIOSCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.93 Cr | -19.94 | |
| Mar2024 | ₹7.41 Cr | 0.82 | |
| Mar2023 | ₹7.35 Cr | 12.92 | |
| Mar2022 | ₹6.51 Cr | -10.53 | |
| Mar2021 | ₹7.28 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,332.0 Cr | 2.4% | 7.4% | -13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 2.4% |
7.4% |
-13.6% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses